Clear cell papillary renal cell carcinoma: Characteristics and survival outcomes from a large single institutional series

被引:7
|
作者
Steward, James E. [1 ]
Kern, Sean Q. [1 ]
Cheng, Liang [2 ]
Boris, Ronald S. [1 ]
Tong, Yan [3 ]
Bahler, Clint D. [1 ]
Masterson, Timothy A. [1 ]
Cary, K. Clint [1 ]
Kaimakliotis, Hristos [1 ]
Gardner, Thomas [1 ]
Sundaram, Chandru P. [1 ]
机构
[1] Indiana Univ Sch Med, Dept Urol, Indianapolis, IN 46202 USA
[2] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA
[3] Indiana Univ Sch Med, Dept Biostat, Indianapolis, IN 46202 USA
关键词
Kidney neoplasms; Renal cell carcinoma; Clear cell; Papillary; Nephrectomy; DISEASE; EMPHASIS; DISTINCT; KIDNEYS;
D O I
10.1016/j.urolonc.2021.02.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: To investigate the clinical characteristics and survival outcomes of a large clear cell papillary renal cell carcinoma cohort. Methods and Materials: A retrospective review of patients with clear cell papillary renal cell carcinoma at a single academic center was performed after Institutional Review Board approval. Patients underwent either partial or radical nephrectomy from September 2009 to July 2019. Demographic and clinical characteristics, recurrence, and cancer specific and overall survival were reported. Results: A total of 90 patients were included in the study. Median follow up was 26.5 months. Median age was 61 (range 27 to 87). 47.8% of patients were African American. 26.7% of patients had end stage renal disease. 37.8% had multifocal renal tumors. 48.9% underwent partial nephrectomy, while the remainder underwent radical nephrectomy. 43.3% underwent an open surgical approach, 40.0% a robotic approach, and 16.7% a laparoscopic approach. Pathologic stage included T1a (90.0%), T1b (1.1%), and T2b (8.9%). Fuhrman grades 1-3 were present in 18.9%, 77.8%, and 3.3% of patients, respectively. There were no cancer specific deaths. There was one local recurrence and no metastases. The overall survival at a median follow up of 26.5 months was 92.1% (95% confidence interval 83.1%-96.4%). Conclusions: Clear cell papillary renal cell carcinoma typically presents at a low stage and grade and has favorable survival outcomes. A nephron-sparing approach to treatment should be considered when feasible due to the tumor's indolent nature and propensity towards multifocality. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:370.e21 / 370.e25
页数:5
相关论文
共 50 条
  • [31] Renal cell carcinoma with extensive clear cell change sharing characteristics of mucinous tubular and spindle cell carcinoma and papillary renal cell carcinoma
    Kuroda, Naoto
    Tamura, Masato
    Hes, Ondrej
    Michal, Michal
    Kawada, Chiaki
    Shuin, Taro
    Lee, Gang-Hong
    PATHOLOGY INTERNATIONAL, 2009, 59 (09) : 687 - 688
  • [32] Multifocal Synchronous Chromophobe, Papillary, and Clear Cell Renal Cell Carcinoma in a Single Kidney
    Delto, Joan C.
    El Hussein, Siba
    Fukuma, Brett
    Abello, Alejandro
    Alexis, John
    Mastrogiovanni, Luciano
    Bhandari, Akshay
    JOURNAL OF UROLOGICAL SURGERY, 2018, 5 (03): : 200 - 202
  • [33] Frequency of Clear Cell Papillary Renal Cell Carcinoma in Cases of Low Grade Clear Cell Renal Cell Carcinoma: A 12 Year Retrospective Study from a Single Cancer Center
    Gill, S.
    Kandel, S.
    Xu, B.
    LABORATORY INVESTIGATION, 2013, 93 : 212A - 212A
  • [34] Frequency of Clear Cell Papillary Renal Cell Carcinoma in Cases of Low Grade Clear Cell Renal Cell Carcinoma: A 12 Year Retrospective Study from a Single Cancer Center
    Gill, S.
    Kandel, S.
    Xu, B.
    MODERN PATHOLOGY, 2013, 26 : 212A - 212A
  • [35] Expression of Parafibromin in Clear Cell Papillary Renal Cell Carcinoma
    Cui, Chunhua
    Ziober, Amy
    Bing, Zhanyong
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2013, 21 (04) : 322 - 325
  • [36] Comprehensive subgroup analyses of survival outcomes between clear cell renal cell adenocarcinoma and papillary renal cell adenocarcinoma
    Huang, Jingyi
    Huang, Da
    Yan, Jiaqi
    Chen, Tianhe
    Gao, Yi
    Xu, Danfeng
    Na, Rong
    CANCER MEDICINE, 2020, 9 (24): : 9409 - 9418
  • [37] Methylation Profiling of Clear Cell Papillary Renal Cell Carcinoma
    Chen, Fei
    Deng, Fangming
    Serrano, Jonathan
    Cotzia, Paolo
    Snuderl, Matija
    Park, Kyung
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 871 - 872
  • [38] Methylation Profiling of Clear Cell Papillary Renal Cell Carcinoma
    Chen, Fei
    Deng, Fangming
    Serrano, Jonathan
    Cotzia, Paolo
    Snuderl, Matija
    Park, Kyung
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 871 - 872
  • [39] Immunohistochemical Study of Clear Cell Papillary Renal Cell Carcinoma
    Lu, S.
    Lal, P.
    Tomaszewski, J. E.
    Bing, Z.
    LABORATORY INVESTIGATION, 2011, 91 : 208A - 208A
  • [40] Clear Cell Papillary Renal Cell Carcinoma: An Immunohistochemical Study
    Pramick, M. R.
    Ziober, A.
    Bing, Z.
    LABORATORY INVESTIGATION, 2013, 93 : 241A - 242A